Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hood

Showing results (381-390 of 393) with videos related to

Pageof 40
Sort By:
ACS Nano|June 14, 2019
Microphysiological Engineering of Self-Assembled and Perfusable Microvascular Beds for the Production of Vascularized Three-Dimensional Human MicrotissuesJungwook Paek, Sunghee E Park, Qiaozhi Lu, et al.
The Australian and New Zealand Journal of Psychiatry|December 20, 2014
Why academic psychiatry is endangeredScott Henderson, Richard J Porter, Darryl Basset, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and SpecificityNicolas Marzolini, Taylor V Brysgel, Eno-Obong Essien, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.
Science (New York, N.Y.)|September 4, 2025
Order-to-disorder transition due to entropy in layered and 2D carbidesBrian C Wyatt, Yinan Yang, Paweł P Michałowski, et al.
Journal of Medicinal Chemistry|March 4, 2008
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degenerationMoorthy S S Palanki, Hideo Akiyama, Peter Campochiaro, et al.
Nature Communications|July 12, 2018
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitudeJacob S Brenner, Daniel C Pan, Jacob W Myerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2020
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrierOscar A Marcos-Contreras, Colin F Greineder, Raisa Yu Kiseleva, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 20, 2026
Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and SpecificityNicolas Marzolini, Taylor V Brysgel, Ryan J Rahman, et al.
ACS Nano|August 6, 2024
Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial SystemMarco E Zamora, Eno-Obong Essien, Kartik Bhamidipati, et al.
Pageof 40

Showing results (381-390 of 393) with videos related to

Sort By:
Pageof 40
ACS Nano|June 14, 2019
Microphysiological Engineering of Self-Assembled and Perfusable Microvascular Beds for the Production of Vascularized Three-Dimensional Human MicrotissuesJungwook Paek, Sunghee E Park, Qiaozhi Lu, et al.
The Australian and New Zealand Journal of Psychiatry|December 20, 2014
Why academic psychiatry is endangeredScott Henderson, Richard J Porter, Darryl Basset, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and SpecificityNicolas Marzolini, Taylor V Brysgel, Eno-Obong Essien, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.
Science (New York, N.Y.)|September 4, 2025
Order-to-disorder transition due to entropy in layered and 2D carbidesBrian C Wyatt, Yinan Yang, Paweł P Michałowski, et al.
Journal of Medicinal Chemistry|March 4, 2008
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degenerationMoorthy S S Palanki, Hideo Akiyama, Peter Campochiaro, et al.
Nature Communications|July 12, 2018
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitudeJacob S Brenner, Daniel C Pan, Jacob W Myerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2020
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrierOscar A Marcos-Contreras, Colin F Greineder, Raisa Yu Kiseleva, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 20, 2026
Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and SpecificityNicolas Marzolini, Taylor V Brysgel, Ryan J Rahman, et al.
ACS Nano|August 6, 2024
Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial SystemMarco E Zamora, Eno-Obong Essien, Kartik Bhamidipati, et al.
Pageof 40